Literature DB >> 9581828

Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.

S M Wuerzberger1, J J Pink, S M Planchon, K L Byers, W G Bornmann, D A Boothman.   

Abstract

Beta-lapachone (beta-lap) affects a number of enzymes in vitro, including type I topoisomerase (Topo I); however, its exact intracellular target(s) and mechanism of cell killing remain unknown. We compared the cytotoxic responses of MCF-7:WS8 (MCF-7) human breast cancer cells after 4-h pulses of beta-lap or camptothecin (CPT), a known Topo I poison. A direct correlation between loss of survival and apoptosis was seen after beta-lap treatment (LD50 = 2.5 microM). A concentration-dependent, transient sub-2 N preapoptotic cell population was observed at 4-8 h. Estrogen deprivation-induced synchronization and bromodeoxyuridine-labeling studies revealed an apoptotic exit point near the G1-S border. Apoptosis activated by beta-lap was closely correlated with cleavage of lamin B but not with increases in p53/p21 or decreases in bcl-2. Loss of hyperphosphorylated forms of the retinoblastoma protein was observed within 5 h, but cyclins A, B1, and E levels were unaltered for up to 72 h after 5 microM beta-lap. Topo I and Topo IIalpha levels decreased at > 24 h. Logarithmic-phase MCF-7 cells were not affected by < or = 1 microM beta-lap. In contrast, dramatic and irreversible G2-M arrest with no apoptosis was observed in MCF-7 cells treated with 1 microM CPT, monitored for 6-10 days posttreatment. MCF-7 cells treated with supralethal doses of CPT (5 microM) resulted in only approximately 20% apoptosis. No correlation between apoptosis and loss of survival was observed. MCF-7 cells exposed to > 5 microM CPT arrested at key cell cycle checkpoints (i.e., G1, S, and G2-M), with little or no movement for 6 days. Ten-fold increases in p53/p21 and 2-5-fold decreases in bcl-2, Topo I, Topo IIalpha, and cyclins A and B1, with no change in cyclin E, were observed. Temporal decreases in bcl-2 and cleavage of lamin B corresponded to the minimal apoptotic response observed. Beta-lap activated apoptosis without inducing p53/p21 or cell cycle arrest responses and killed MCF-7 cells solely by apoptosis. In contrast, concentration-dependent increases in nuclear p53/p21 and various cell cycle checkpoint arrests were seen in MCF-7 cells after CPT. Despite dramatic p53/p21 protein induction responses, CPT-treated MCF-7 cells showed low levels of apoptosis, possibly due to protective cell cycle checkpoints or the lack of specific CPT-activated apoptotic pathways in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581828

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  26 in total

1.  Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

Authors:  C R Yang; K Leskov; K Hosley-Eberlein; T Criswell; J J Pink; T J Kinsella; D A Boothman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Ortho-quinone-enhanced ascorbate oxidation. Combined roles of lipid charge and the magnesium cation.

Authors:  Antonio E Alegría; Pedro Sanchez-Cruz
Journal:  Toxicol Environ Chem       Date:  2008-03-01       Impact factor: 1.437

3.  Synergistic effect of ionizing radiation and beta-Lapachone against RKO human colon adenocarcinoma cells.

Authors:  Eun Jung Kim; In-Mi Ji; Ki-Jung Ahn; Eun Kyung Choi; Heon-Jin Park; Byung Uk Lim; Chang W Song; Heon Joo Park
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 4.  New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.

Authors:  Melissa S Bentle; Erik A Bey; Ying Dong; Kathryn E Reinicke; David A Boothman
Journal:  J Mol Histol       Date:  2006-07-26       Impact factor: 3.156

5.  Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints.

Authors:  C J Li; Y Z Li; A V Pinto; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 12.779

6.  Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy.

Authors:  Bae Hyun Shin; Yunki Lim; Hye Jin Oh; Sang Min Park; Sun-Kyung Lee; Joohong Ahnn; Do Han Kim; Woo Keun Song; Tae Hwan Kwak; Woo Jin Park
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.752

7.  Enhancement of radiation effect using beta-lapachone and underlying mechanism.

Authors:  Ki Jung Ahn; Hyung Sik Lee; Se Kyung Bai; Chang Won Song
Journal:  Radiat Oncol J       Date:  2013-06-30

8.  An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.

Authors:  Erik A Bey; Melissa S Bentle; Kathryn E Reinicke; Ying Dong; Chin-Rang Yang; Luc Girard; John D Minna; William G Bornmann; Jinming Gao; David A Boothman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 12.779

9.  Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.

Authors:  Victor Mangas-Sanjuan; Jorge Gutiérrez-Nieto; Magdalena Echezarreta-López; Isabel González-Álvarez; Marta González-Álvarez; Vicente-Germán Casabó; Marival Bermejo; Mariana Landin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.569

10.  Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.

Authors:  Norased Nasongkla; Andy F Wiedmann; Andrew Bruening; Meghan Beman; Dale Ray; William G Bornmann; David A Boothman; Jinming Gao
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.